Personalized Medicine 5.0
The Role of Epigenetics

Thursday, 24 May 2012
8 a.m. - 7:30 p.m.
South San Francisco Conference Center


The advent of low-cost sequencing of the human genome will revolutionize our understanding of health and disease. Personalized medicine seeks to use genetic variation to develop new diagnostic tests and treatments and to identify the sub-groups of patients for whom they will work best. Personalized medicine can also help determine which groups of patients are more prone to developing some diseases and, ideally, help with the selection of lifestyle changes and/or treatments that can delay onset of disease or reduce its impact. Personalized medicine is poised to transform healthcare over the next several decades, offering the possibility of improved health outcomes and making healthcare more cost-effective. Yet it has become abundantly clear that the DNA sequence itself is only part of the story. The regulation of gene expression, and how it changes in health and disease, and in response to therapy, is crucial. This year, our conference focuses on the exciting area of epigenetics, or genetic change above and beyond the DNA sequence level, with profound implications for personalized medicine, pharmacogenomics, aging and oncology. Come witness the transformation as it is happening.


Harvesting the fruits of molecular genetics
for a Third Millennium medicine
Unleashing the power of preventive medicine
Stratifying human disease


Personalized Medicine — The Time is Now

For further information or to sponsor this event,
email us at dnamed@sfsu.edu


We are happy to accommodate persons with special access requirements.
Please contact Arlene Essex at 415.405.4107

logos of sponsors link to Genentech <link to biomarin> <<link to swedish biomimetics>> <link to sf state department of biology> <link to city of south san francisco> <celgene> <pwc> <biosearch technologies> <kenson ventures> <genelex> <personalized medicine coalition> <bay bio> <link to bioquick news> ink to bioscience forum<empty>